Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin Enacarbil Effects on Sleep Arousal in RLS
NCT02424695Phase 4Unknown
- Sponsor
- Cleveland Sleep Research Center
- Start
- Jun 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gabapentin enacarbil in restless legs syndrome (RLS), sponsored by Cleveland Sleep Research Center. Status: unknown.
02
Drugs
gabapentin enacarbil
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT02424695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02424695.